Nephritic vs Nephrotic Syndrome — Overview
Written 27th August 2020 - Last Update 23rd July 2026
Nephritic vs Nephrotic Syndrome — Overview
Glomerulonephropathies affect glomerular structure and function, characterised by
haematuria, red cell casts, or proteinuria. They’re classified into nephrotic syndrome,
nephritic syndrome, or non-nephrotic proteinuria — though there is considerable overlap. See
nephrotic-syndrome.md for detailed nephrotic-syndrome-specific complications and
management.
Nephrotic syndrome
Proteinuria >3.5 g/1.73m²/24h, hypoalbuminaemia, oedema, hyperlipidaemia, lipiduria — practically, heavy proteinuria plus oedema from low albumin. Generally a non-inflammatory process.
Most common causes: diabetes (by far the most common), SLE, HIV/hepatitis B/C, focal segmental glomerulosclerosis, minimal change disease, membranous nephropathy, membranoproliferative GN.
Usually presents with oedema, or is picked up when checking for albuminuria in hypertension or diabetes.
Nephritic syndrome
Haematuria ± red cell casts, variable proteinuria, renal insufficiency, salt retention
(hypertension and oedema). Characterised by an inflammatory process — this is how
glomerulonephritis presents (see glomerulonephritis.md). May be intrinsic renal disease or
secondary to a systemic cause.
Typically presents with oedema, oliguria, or hypertension; may be picked up incidentally as microscopic haematuria, or occasionally dark/tea-coloured urine.
Causes:
- Post-streptococcal glomerulonephritis — see
post-strep-glomerulonephritis.md - IgA nephropathy — the most common cause — see
iga-nephropathy.md - Lupus nephritis
- Rapidly progressive GN: anti-GBM disease (including Goodpasture syndrome), immune complex
deposition disease (e.g. IgA vasculitis/HSP — see
vasculitis.md)
Investigations
As for haematuria and glomerulonephritis generally: urinalysis + microscopy, ASO titre, anti-GBM antibody, ANCA, ANA, hepatitis serology (if risk factors or hepatomegaly), renal ultrasound. Kidney biopsy is often needed to make the diagnosis.
Management
Refer promptly — particularly urgently if rapidly progressive disease is suspected.